Krystal Biotech Expects 2026 Adjusted Research and Administrative Costs
Krystal Biotech expects adjusted research and administrative expenses in 2026.
Related stories
Site Centers Q3 FFO per Share: USD -0.06
L impact | EARNINGS | Nov 02, 2026, 09:20 PM UTC
Upwork Sees 4Q Adjusted EPS of 30c–32c
M impact | EARNINGS | Nov 02, 2026, 09:18 PM UTC
People Incorporated forecasts FY2026 operating income of $6M-$49M
M impact | EARNINGS | Nov 02, 2026, 09:18 PM UTC
Upwork Sees Fourth-Quarter Revenue of $169M-$177M
Upwork sees fourth-quarter revenue of $169 million to $177 million.
M impact | EARNINGS | Nov 02, 2026, 09:18 PM UTC
People Incorporated sets FY2026 adjusted EBITDA outlook at $263M-$283M
M impact | EARNINGS | Nov 02, 2026, 09:18 PM UTC
Vitesse Energy reports a net loss in Q3 2026
M impact | EARNINGS | Nov 02, 2026, 09:17 PM UTC